Conversely, in the CG, there were significantly more patients with compensated hypogonadism, defined as having a total testosterone value of ≥12 nmol/l with increased LH and/or FSH levels (p = 0.005) (see Table 4). The gene discussed is PLOD1; the disease is hypogonadism.